【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 12
2 Introduction 13
2.1 Hepatitis Viruses Overview 13
3 Products under Development 14
3.1 Hepatitis Viruses – Pipeline Products by Stage of Development 14
3.2 Hepatitis Viruses – Pipeline Products by Territory 15
3.3 Hepatitis Viruses – Pipeline Products by Regulatory Path 16
3.4 Hepatitis Viruses – Pipeline Products by Estimated Approval Date 17
3.5 Hepatitis Viruses – Ongoing Clinical Trials 18
4 Hepatitis Viruses – Pipeline Products under Development by Companies 19
4.1 Hepatitis Viruses Companies – Pipeline Products by Stage of Development 19
4.2 Hepatitis Viruses – Pipeline Products by Stage of Development 22
5 Hepatitis Viruses Companies and Product Overview 27
5.1 Abbott Diagnostics Company Overview 27
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 27
5.2 Access Bio, Inc. Company Overview 43
5.2.1 Access Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.3 Alderon Biosciences, Inc. Company Overview 44
5.3.1 Alderon Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
5.4 Alere Inc. Company Overview 45
5.4.1 Alere Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
5.5 AXO Science S.A.S. Company Overview 47
5.5.1 AXO Science S.A.S. Pipeline Products & Ongoing Clinical Trials Overview 47
5.6 Beckman Coulter, Inc. Company Overview 48
5.6.1 Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.7 Biokit, S.A. Company Overview 51
5.7.1 Biokit, S.A. Pipeline Products & Ongoing Clinical Trials Overview 51
5.8 Biomagnetics Diagnostics Corporation (Inactive) Company Overview 55
5.8.1 Biomagnetics Diagnostics Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55
5.9 Bio-Rad Laboratories, Inc. Company Overview 56
5.9.1 Bio-Rad Laboratories, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.10 CeMines, Inc. Company Overview 59
5.10.1 CeMines, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.11 Cepheid Company Overview 60
5.11.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 60
5.12 China Medical Technologies, Inc. Company Overview 64
5.12.1 China Medical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.13 Co-Diagnostics HBDC, Inc. Company Overview 66
5.13.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.14 Corgenix Medical Corporation Company Overview 67
5.14.1 Corgenix Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 67
5.15 Da An Gene Co., Ltd. Company Overview 69
5.15.1 Da An Gene Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 69
5.16 Diagnostics for the Real World (Europe) Ltd. Company Overview 74
5.16.1 Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 74
5.17 DiaSorin S.p.A Company Overview 75
5.17.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 75
5.18 D-Kimia, LLC. Company Overview 78
5.18.1 D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview 78
5.19 Ecoli s.r.o. Company Overview 79
5.19.1 Ecoli s.r.o. Pipeline Products & Ongoing Clinical Trials Overview 79
5.20 Enzo Biochem, Inc. Company Overview 98
5.20.1 Enzo Biochem, Inc. Pipeline Products & Ongoing Clinical Trials Overview 98
5.21 Epistem Holdings Plc Company Overview 100
5.21.1 Epistem Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 100
5.22 Fast-track diagnostics S.a.r.l. Company Overview 102
5.22.1 Fast-track diagnostics S.a.r.l. Pipeline Products & Ongoing Clinical Trials Overview 102
5.23 Genera Biosystems Limited Company Overview 109
5.23.1 Genera Biosystems Limited Pipeline Products & Ongoing Clinical Trials Overview 109
5.24 General Biologicals Corporation Company Overview 111
5.24.1 General Biologicals Corporation Pipeline Products & Ongoing Clinical Trials Overview 111
5.25 GenMark Diagnostics, Inc. Company Overview 114
5.25.1 GenMark Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 114
5.26 Hologic, Inc. Company Overview 116
5.26.1 Hologic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 116
5.27 InstantLabs Medical Diagnostics Corporation Company Overview 121
5.27.1 InstantLabs Medical Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview 121
5.28 Institut National de la Sante et de la Recherche Medicale Company Overview 122
5.28.1 Institut National de la Sante et de la Recherche Medicale Pipeline Products & Ongoing Clinical Trials Overview 122
5.29 MedMira Inc. Company Overview 123
5.29.1 MedMira Inc. Pipeline Products & Ongoing Clinical Trials Overview 123
5.30 Mindray Medical International Limited Company Overview 130
5.30.1 Mindray Medical International Limited Pipeline Products & Ongoing Clinical Trials Overview 130
5.31 MND Diagnostic LTD Company Overview 137
5.31.1 MND Diagnostic LTD Pipeline Products & Ongoing Clinical Trials Overview 137
5.32 NanoDiagX Company Overview 139
5.32.1 NanoDiagX Pipeline Products & Ongoing Clinical Trials Overview 139
5.33 OPKO Health, Inc. Company Overview 141
5.33.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 141
5.34 Pathogenica, Inc. Company Overview 144
5.34.1 Pathogenica, Inc. Pipeline Products & Ongoing Clinical Trials Overview 144
5.35 Polartechnics Limited Company Overview 145
5.35.1 Polartechnics Limited Pipeline Products & Ongoing Clinical Trials Overview 145
5.36 ProteinLogic Ltd Company Overview 146
5.36.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 146
5.37 Qiagen N.V. Company Overview 147
5.37.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 147
5.38 Quotient Limited Company Overview 150
5.38.1 Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 150
5.39 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 152
5.39.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 152
5.40 Roche Diagnostics GmbH Company Overview 153
5.40.1 Roche Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview 153
5.41 Roche Diagnostics International Ltd. Company Overview 155
5.41.1 Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview 155
5.42 Sedia Biosciences Corporation Company Overview 168
5.42.1 Sedia Biosciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 168
5.43 Siemens Healthcare Diagnostics Inc. Company Overview 169
5.43.1 Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 169
5.44 Stanford University Company Overview 179
5.44.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 179
5.45 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview 181
5.45.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 181
5.46 The Johns Hopkins University Company Overview 183
5.46.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 183
5.47 TrovaGene, Inc. Company Overview 184
5.47.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.48 University of California, Irvine Company Overview 186
5.48.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 186
5.49 University of Texas Medical Branch at Galveston Company Overview 187
5.49.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 187
5.50 University of Warwick Company Overview 188
5.50.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 188
5.51 Vela Diagnostics Company Overview 189
5.51.1 Vela Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 189
5.52 Xagenic Inc. Company Overview 192
5.52.1 Xagenic Inc. Pipeline Products & Ongoing Clinical Trials Overview 192
5.53 Xiamen Zeesan Biotech Co.,Ltd Company Overview 193
5.53.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 193
6 Hepatitis Viruses- Recent Developments 194
7 Appendix 225
7.1 Methodology 225
7.2 About GlobalData 227
7.3 Contact Us 228
7.4 Disclaimer 228
【レポート販売概要】
■ タイトル：世界における肝炎ウイルス検査製品のパイプライン動向2015■ 英文：Hepatitis Viruses - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0075EPD
■ 調査対象地域：グローバル
- ヘルスケアBPOの世界市場予測（～2022年）“The healthcare BPO market is projected to grow at a CAGR of 10.2%.”The healthcare BPO market is expected to grow at a CAGR of 10.2% from 2017 to 2022, to reach USD 312.43 billion by 2022 from USD 191.68 billion in 2017. The need to reduce the rising healthcare costs and the implementation of the Patient Protection and Affordable Care Act (PPACA) are factors that compel payers and providers to out …
- 世界のバイオプラスチック・パッケージング市場：Global Bioplastic Packaging Market 2014-2018TechNavio's analysts forecast the Global Bioplastic Packaging market to grow at a CAGR of 19.85 percent over the period 2013-2018. One of the key factors contributing to this market growth is the growing concern for environmentally-friendly packaging. The Global Bioplastic Packaging market has also been witnessing the increasing demand from emerging countries. However, the premium pricing of biopl …
- Machine-to-Machine (M2M) and Radio Frequency ID (RFID) Second EditionMachine-to-Machine (M2M) communications and Radio Frequency ID (RFID) together represent a means of direct communication between connection hardware and the object that needs monitoring: the information about its status of performance is directly sent to a computer system without the need for human intervention. This makes automation of processes or consumer action possible. The technology that ut …
- 研磨材の世界市場：固定砥粒、被覆砥粒、超砥粒About Abrasives Abrasives are materials that are used to grind, abrade, or clean workpieces to give desired shape and finish. They are of different types, but can be broadly classified into bonded, coated, loose abrasive grains, super abrasives, and others. The basic raw materials used to make abrasives are ceramics, diamonds, and naturally occurring elements. Abrasives are used for polishing surf …
- 世界の水処理添加物市場2015The Global Water Treatment Additives Industry Report 2015 is a professional and in-depth study on the current state of the Water Treatment Additives industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Water Treatment Additives market analysis is provided for the international markets including develop …
- 軍用オプトロニクス、監視、照準装置の世界市場：画像増強装置、赤外線装置、レーザー装置、カメラシステム等The drive towards highly advanced individual warfighter systems is currently picking up speed in both Europe and North America, where land forces are looking to equip the individual soldier with the optical devices, personnel protective equipment, and intelligence capabilities to enable them to perform on the modern battlefield. Presently, this is not a trend that is being replicated in other regi …
- 短距離防空（SHORAD）ミサイルシステムの世界市場2016-2020About SHORAD Missile SystemShort Range Air Defense (SHORAD) missile system is a weapon or technology that involves detection, tracking, interception, and destruction of attacking short-range missiles. Originally, ADMS was used as a defense against nuclear-armed and intercontinental ballistic missiles (ICBMs); however, its application has widened to defense against short-ranged non-nuclear tactical …
- アメリカのアダルト・バイブレータ市場About the Adult Vibrator Market in the US Vibrators were initially used by women who had difficulty reaching orgasm through masturbation or intercourse. Today, vibrators are used to create sexual stimulation and enhance orgasm, even during intercourse. There are several types of vibrators with different applications. Technavio’s analysts forecast the adult vibrator market in the US to grow at a CA …
- HDMI及びディスプレイポートの世界市場2016-2020About HDMI and DisplayPort HDMI, which expands to High-Definition Multimedia Interface, was developed in 2002. It is a registered audio/video (A/V) interface that transfers video and audio data from a compliant source device (such as display controllers) to a display device (such as PC monitors, projectors, televisions, or digital audio devices). DisplayPort is an A/V interface developed by the Vi …
- 世界の食品香料市場動向及び予測（～2018）A wide range of flavors can be used alone or in conjunction with other food flavors for the desired taste. These are used in processed food because over processing destroys the flavor. A few of the common effects induced by synthetic flavors are headache, migraine, joint pain, etc. Therefore, effective and safe natural flavors are actively in demand. Also, consumer perception regarding the benefit …
- 医薬品有効成分（原薬/API）の世界市場About Active Pharmaceutical Ingredients Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used …
- 世界のフリート管理システム市場動向（2012-2016）TechNavio's analysts forecast the Global Fleet Management System market to grow at a CAGR of 26.66 percent over the period 2012-2016. One of the key factors contributing to this market growth is the expansion of fleet size of commercial vehicles. The Global Fleet Management System market has also been witnessing an increasing number of in-vehicle technologies. However, the increasing operating cos …
- クラウド侵入検知・防止システム（IDP）の世界市場2016-2020About Cloud Intrusion Detection and Prevention Increasing cases of cyber attacks have compelled enterprises to increase their spending on IT infrastructure to prevent theft of data. IDSs identify malicious activities over the network and intrusion prevention systems (IPSs) prevent data modification or unauthorized access. IDSs and IPSs include hardware, software, and services. IDS is a passive mon …
- 脳血管攣縮（Cerebral Vasospasm）：グローバル臨床試験レビュー（2014年上半期）Cerebral Vasospasm Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Cerebral Vasospasm Global Clinical Trials Review, H1, 2014" provides data on the Cerebral Vasospasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cerebral Vasospasm. It includes an overview of the trial numbers and their recruitme …
- カプリル酸の世界市場分析：用途別（パーソナルケア、医薬品、食品･飲料）、セグメント予測The global caprylic acid market is expected to reach USD 4.4 million by 2022, according to a new report by Grand View Research, Inc. Widespread use of caprylic acid in personal care, and pharmaceutical industry coupled with the growth of these end-use industries is expected to drive growth. Furthermore, growing demand for the acid in manufacturing pesticides and surfactants is expected to propel m …
